disopyramide has been researched along with Neurally Mediated Faint in 13 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vasovagal syncope is the most common abnormal response to upright posture and occurs in all age groups." | 2.41 | Strategy for the management of vasovagal syncope. ( Bloomfield, DM, 2002) |
| "When vasovagal syncope was induced (positive response), the HUT was repeated to examine the test reproducibility." | 1.30 | Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing. ( Baba, T; Chiyoda, K; Katagiri, T; Kikushima, S; Kobayashi, Y; Miyata, A; Nakagawa, H; Obara, C; Shinohara, M; Tanno, K; Zinbo, Y, 1998) |
| "Vasovagal syncope is a common disorder of autonomic cardiovascular regulation that can be very disabling and result in a significant level of psychosocial and physical limitations." | 1.30 | Management of vasovagal syncope. ( Atiga, WL; Calkins, H; Rowe, P, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Porr, WA | 1 |
| Kaufmann, H | 1 |
| Freeman, R | 1 |
| Verma, S | 1 |
| Hackel, JG | 1 |
| Torrisi, DJ | 1 |
| Nguyen, T | 1 |
| Pentousis, D | 1 |
| Cooper, JP | 1 |
| Cobbe, SM | 1 |
| Deal, BJ | 1 |
| Strieper, M | 1 |
| Scagliotti, D | 1 |
| Hulse, E | 1 |
| Auld, D | 1 |
| Campbell, R | 1 |
| Strasburger, JF | 1 |
| Benson, DW | 1 |
| Wolff, GS | 1 |
| Nakagawa, H | 1 |
| Kobayashi, Y | 1 |
| Kikushima, S | 1 |
| Shinohara, M | 1 |
| Obara, C | 1 |
| Zinbo, Y | 1 |
| Chiyoda, K | 1 |
| Miyata, A | 1 |
| Tanno, K | 1 |
| Baba, T | 1 |
| Katagiri, T | 1 |
| Kadri, NN | 1 |
| Hee, TT | 1 |
| Rovang, KS | 1 |
| Mohiuddin, SM | 1 |
| Ryan, T | 1 |
| Ashraf, R | 1 |
| Huebert, V | 1 |
| Hilleman, DE | 1 |
| Atiga, WL | 1 |
| Rowe, P | 1 |
| Calkins, H | 1 |
| Deharo, JC | 1 |
| Peyre, JP | 1 |
| Chalvidan, T | 1 |
| Thirion, X | 1 |
| Valli, M | 1 |
| Ritter, P | 1 |
| Djiane, P | 1 |
| Granowitz, EV | 1 |
| Tabor, KJ | 1 |
| Kirchhoffer, JB | 1 |
| Cadman, CS | 1 |
| Bloomfield, DM | 1 |
6 reviews available for disopyramide and Neurally Mediated Faint
| Article | Year |
|---|---|
Pharmacological treatment of reflex syncope.
Topics: Adrenergic Agents; Anti-Arrhythmia Agents; Cholinergic Antagonists; Disopyramide; Humans; Selective | 2004 |
Syncope in athletes: a guide to getting them back on their feet.
Topics: Adolescent; Anti-Arrhythmia Agents; Diagnosis, Differential; Disopyramide; Electrocardiography; Exer | 2007 |
Unexplained syncope: clinical management.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Behavior Ther | 1997 |
Potentially fatal interaction between azithromycin and disopyramide.
Topics: Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Azithromycin; Cat-Scratch Disease; Disopyramid | 2000 |
Medical therapy of neurocardiogenic syncope.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Child; Cholinergic Antago | 2001 |
Strategy for the management of vasovagal syncope.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Ca | 2002 |
1 trial available for disopyramide and Neurally Mediated Faint
| Article | Year |
|---|---|
Efficacy and safety of clonazepam in refractory neurally mediated syncope.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Clonazepam; Disopyramide; Drug Therapy, Combina | 1999 |
6 other studies available for disopyramide and Neurally Mediated Faint
| Article | Year |
|---|---|
Is this form of syncope to blame?
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Disopyramide; Humans; Medical History Taking; N | 2004 |
Prolonged asystole induced by head up tilt test. Report of four cases and brief review of the prognostic significance and medical management.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Disopyramide; Female; Heart | 1997 |
The medical therapy of cardioinhibitory syncope in pediatric patients.
Topics: Adrenergic Agonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Child; Cohort Studies; Disopy | 1997 |
Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
Topics: Administration, Oral; Adult; Disopyramide; Female; Follow-Up Studies; Head-Down Tilt; Humans; Inject | 1998 |
Management of vasovagal syncope.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Cardiac Pacing, Artificial; Disopyram | 1999 |
Continuous monitoring of an endocardial index of myocardial contractility during head-up tilt test.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Cardiotonic Agents; Disopyramide; Dobutamine; E | 2000 |